What separates the document from similar provincial plans is how directly it writes geography into industrial positioning. Fujian is cast as a cross-strait hub for BCI innovation cooperation and a national demonstration base for distinctive applications, with an explicit call to build a cross-strait joint laboratory together with research institutions and companies in Taiwan. Industry organisation is anchored on the Fuzhou-Xiamen-Quanzhou national innovation demonstration zone, which is also to steer dedicated funding. Product priorities run to both ends of the market: brain-controlled rehabilitation robots, limb rehabilitation trainers, brain-controlled wheelchairs, assisted therapy systems and AR/VR post-operative rehabilitation devices on the medical side; brain-controlled remote manipulators, drone detection aids and brain-machine intelligent cockpits on the industrial side. On the clinical track, universities and top-tier hospitals are to build trial bases, set up dedicated research wards, assemble pre-enrolment cohorts, and develop clinical evaluation and ethics standards.
Fujian Targets a 3 Billion Yuan BCI Industry by 2030
Summary
Six Fujian government departments jointly issued a provincial BCI action plan for 2026–2030. It calls for key technical breakthroughs, more than five innovative small and medium-sized companies, one cross-strait joint laboratory and two provincial innovation platforms by 2027; by 2030, Fujian aims to have 30 companies, a complete industry chain and an industry worth more than 3 billion yuan.
Why it matters
The plan adds measurable provincial targets to China's national BCI policy push, while its proposed cross-strait laboratory gives Fujian a distinctive regional strategy.
Compiled by BCIwiki from public sources
Sources · 1
kjt.fujian.gov.cn 2026-08-18